Iol Chemicals And Pharmaceu Share Price
Sector: Chemical Manufacturing
65.89 -2.84 (-4.13%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
64.82
Today’s High
69.50
52 Week Low
57.51
52 Week High
107.41
66.08 -2.71 (-3.94%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
64.72
Today’s High
69.45
52 Week Low
57.50
52 Week High
107.54
Key Metrics
- Market Cap (In Cr) 1939.92
- Beta 1.31
- Div. Yield (%) 1.21
- P/B 1.2
- TTM P/E 24.58
- Sector P/E 28.96
- Open Price 69.5
- Prev Close 68.73
Iol Chemicals And Pharmaceu Analysis
Price Analysis
-
1 Week-0.97%
-
3 Months-12.83%
-
6 Month-12.48%
-
YTD-18.93%
-
1 Year-17.47%
Risk Meter
- 44% Low risk
- 44% Moderate risk
- 44% Balanced Risk
- 44% High risk
- 44% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 2
- 2
- 2
- 2
- Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 2
- 2
- 2
- 2
Iol Chemicals And Pharmaceu News
Balaji Amines, Deepak Nitrite among 6 chemical stock picks by Vaishali Parekh
4 min read . 06 Apr 2024Buy or sell: Vaishali Parekh recommends three stocks to buy today — August 28
2 min read . 28 Aug 2023Indian maker of Ibuprofen rallies as coronavirus disrupts China supply
1 min read . 25 Feb 2020Iol Chemicals And Pharmaceu Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 2132.79
- Selling/ General/ Admin Expenses Total
- 432.25
- Depreciation/ Amortization
- 62.98
- Other Operating Expenses Total
- 46.72
- Total Operating Expense
- 1965.05
- Operating Income
- 167.74
- Net Income Before Taxes
- 181.65
- Net Income
- 134.43
- Diluted Normalized EPS
- 4.58
- Period
- 2024
- Total Assets
- 2244.4
- Total Liabilities
- 632.89
- Total Equity
- 1611.51
- Tangible Book Valueper Share Common Eq
- 54.47
- Period
- 2024
- Cashfrom Operating Activities
- 290.08
- Cashfrom Investing Activities
- -191.28
- Cashfrom Financing Activities
- -92.5
- Net Changein Cash
- 6.3
- Period
- 2023
- Total Revenue
- 2217.11
- Selling/ General/ Admin Expenses Total
- 382.05
- Depreciation/ Amortization
- 46.23
- Other Operating Expenses Total
- 32
- Total Operating Expense
- 2036.99
- Operating Income
- 180.12
- Net Income Before Taxes
- 188.65
- Net Income
- 139.14
- Diluted Normalized EPS
- 4.76
- Period
- 2023
- Total Assets
- 2022.13
- Total Liabilities
- 514.41
- Total Equity
- 1507.72
- Tangible Book Valueper Share Common Eq
- 51.06
- Period
- 2023
- Cashfrom Operating Activities
- 122.27
- Cashfrom Investing Activities
- -120
- Cashfrom Financing Activities
- -4.11
- Net Changein Cash
- -1.84
- Period
- 2022
- Total Revenue
- 2184.02
- Selling/ General/ Admin Expenses Total
- 303.42
- Depreciation/ Amortization
- 43.26
- Other Operating Expenses Total
- 24.54
- Total Operating Expense
- 1981.81
- Operating Income
- 202.21
- Net Income Before Taxes
- 224.85
- Net Income
- 167.67
- Diluted Normalized EPS
- 6.09
- Period
- 2022
- Total Assets
- 1962.3
- Total Liabilities
- 570.02
- Total Equity
- 1392.28
- Tangible Book Valueper Share Common Eq
- 47.32
- Period
- 2022
- Cashfrom Operating Activities
- 93.05
- Cashfrom Investing Activities
- -120.19
- Cashfrom Financing Activities
- -1.64
- Net Changein Cash
- -28.78
- Period
- 2021
- Total Revenue
- 1966.98
- Selling/ General/ Admin Expenses Total
- 235.83
- Depreciation/ Amortization
- 38.92
- Other Operating Expenses Total
- 14.97
- Total Operating Expense
- 1413.89
- Operating Income
- 553.09
- Net Income Before Taxes
- 571.39
- Net Income
- 444.56
- Diluted Normalized EPS
- 15.25
- Period
- 2021
- Total Assets
- 1610.09
- Total Liabilities
- 349.66
- Total Equity
- 1260.43
- Tangible Book Valueper Share Common Eq
- 44.31
- Period
- 2021
- Cashfrom Operating Activities
- 379.78
- Cashfrom Investing Activities
- -317.25
- Cashfrom Financing Activities
- -58.28
- Net Changein Cash
- 4.25
- Period
- 2020
- Total Revenue
- 1894.47
- Selling/ General/ Admin Expenses Total
- 224.11
- Depreciation/ Amortization
- 35.73
- Other Operating Expenses Total
- 11.8
- Total Operating Expense
- 1356.29
- Operating Income
- 538.18
- Net Income Before Taxes
- 533.24
- Net Income
- 361.29
- Diluted Normalized EPS
- 12.7
- Period
- 2020
- Total Assets
- 1175.56
- Total Liabilities
- 362.02
- Total Equity
- 813.54
- Tangible Book Valueper Share Common Eq
- 28.59
- Period
- 2020
- Cashfrom Operating Activities
- 471.09
- Cashfrom Investing Activities
- -184.52
- Cashfrom Financing Activities
- -271.89
- Net Changein Cash
- 14.68
- Period
- 2019
- Total Revenue
- 1685.33
- Selling/ General/ Admin Expenses Total
- 197.85
- Depreciation/ Amortization
- 32.45
- Other Operating Expenses Total
- 10.84
- Total Operating Expense
- 1308.09
- Operating Income
- 377.24
- Net Income Before Taxes
- 336.15
- Net Income
- 236.7
- Diluted Normalized EPS
- 8.42
- Period
- 2019
- Total Assets
- 941.88
- Total Liabilities
- 467.54
- Total Equity
- 474.34
- Tangible Book Valueper Share Common Eq
- 16.66
- Period
- 2019
- Cashfrom Operating Activities
- 273.17
- Cashfrom Investing Activities
- -63.04
- Cashfrom Financing Activities
- -197.46
- Net Changein Cash
- 12.67
- Period
- 2024-12-31
- Total Revenue
- 523.3
- Selling/ General/ Admin Expenses Total
- 52.43
- Depreciation/ Amortization
- 18.68
- Other Operating Expenses Total
- 69.95
- Total Operating Expense
- 495.11
- Operating Income
- 28.19
- Net Income Before Taxes
- 27.8
- Net Income
- 20.53
- Diluted Normalized EPS
- 0.7
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 525.75
- Selling/ General/ Admin Expenses Total
- 58.7
- Depreciation/ Amortization
- 17.94
- Other Operating Expenses Total
- 69.84
- Total Operating Expense
- 502.12
- Operating Income
- 23.63
- Net Income Before Taxes
- 25.94
- Net Income
- 19.15
- Diluted Normalized EPS
- 0.65
- Period
- 2024-09-30
- Total Assets
- 2265.1
- Total Liabilities
- 605.82
- Total Equity
- 1659.28
- Tangible Book Valueper Share Common Eq
- 56.09
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -3.14
- Cashfrom Investing Activities
- -75.56
- Cashfrom Financing Activities
- 89.39
- Net Changein Cash
- 10.69
- Period
- 2024-06-30
- Total Revenue
- 502.38
- Selling/ General/ Admin Expenses Total
- 53.05
- Depreciation/ Amortization
- 16.82
- Other Operating Expenses Total
- 61.85
- Total Operating Expense
- 468.09
- Operating Income
- 34.29
- Net Income Before Taxes
- 39.52
- Net Income
- 29.97
- Diluted Normalized EPS
- 1.02
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 503.92
- Selling/ General/ Admin Expenses Total
- 49.65
- Depreciation/ Amortization
- 16.43
- Other Operating Expenses Total
- 82.23
- Total Operating Expense
- 470.83
- Operating Income
- 33.09
- Net Income Before Taxes
- 37.2
- Net Income
- 27.62
- Diluted Normalized EPS
- 0.94
- Period
- 2024-03-31
- Total Assets
- 2244.4
- Total Liabilities
- 632.89
- Total Equity
- 1611.51
- Tangible Book Valueper Share Common Eq
- 54.47
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 290.08
- Cashfrom Investing Activities
- -191.28
- Cashfrom Financing Activities
- -92.5
- Net Changein Cash
- 6.3
- Period
- 2023-12-31
- Total Revenue
- 520.39
- Selling/ General/ Admin Expenses Total
- 48.29
- Depreciation/ Amortization
- 16.34
- Other Operating Expenses Total
- 71.8
- Total Operating Expense
- 492.38
- Operating Income
- 28.01
- Net Income Before Taxes
- 32.09
- Net Income
- 23.08
- Diluted Normalized EPS
- 0.79
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Iol Chemicals And Pharmaceu Technical
Moving Average
SMA
- 5 Day67.38
- 10 Day65.22
- 20 Day63.74
- 50 Day65.52
- 100 Day72.41
- 300 Day78.91
Iol Chemicals And Pharmaceu Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Insecticides India
- 710.2
- -14.65
- -2.02
- 1084.65
- 475.5
- 2071.48
- Yasho Industries
- 1681
- -45.75
- -2.65
- 2330
- 1600.1
- 1918.54
- Iol Chemicals And Pharmaceu
- 65.89
- -2.84
- -4.13
- 107.41
- 57.51
- 1939.92
- Meghmani Organics
- 70.65
- -2.99
- -4.06
- 116
- 57
- 1798.76
- India Pesticides
- 148.05
- -6.45
- -4.17
- 263.85
- 119.85
- 1705
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Insecticides India
- 20.88
- 2.08
- 10.86
- 5.63
- Yasho Industries
- 33.09
- 6.5
- 29.48
- 8.35
- Iol Chemicals And Pharmaceu
- 14.43
- 1.2
- 20.73
- 12
- Meghmani Organics
- -
- 1.18
- 12.72
- 8.73
- India Pesticides
- 28.36
- 2.07
- -
- -
Iol Chemicals And Pharmaceu Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 12-Feb-25
- Quarterly Results & Interim Dividend
- 27-Dec-24
- Stock Split
- 14-Nov-24
- Quarterly Results
- 09-Aug-24
- Quarterly Results
- 14-May-24
- Audited Results
- 06-Feb-24
- Quarterly Results & Interim Dividend
- 08-Nov-23
- Quarterly Results
- 09-Aug-23
- Quarterly Results
- 28-Apr-23
- Audited Results
- 07-Feb-23
- Audited Results & Interim Dividend
- Meeting Date
- Announced on
- Purpose
- 02-Feb-25
- 01-Jan-25
- POM
- 14-Dec-24
- 12-Nov-24
- POM
- 23-Aug-24
- 14-May-24
- AGM
- 10-Aug-23
- 28-Apr-23
- AGM
- 20-Mar-22
- 16-Feb-22
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 12-Feb-25
- 18-Feb-25
- 18-Feb-25
- 4
- 06-Feb-24
- 16-Feb-24
- 16-Feb-24
- 5
- 07-Feb-23
- 17-Feb-23
- 17-Feb-23
- 4
- 04-Feb-22
- 16-Feb-22
- 15-Feb-22
- 4
- 04-Jun-21
- -
- 08-Sept-21
- 2

- Ex-Splits
- Old FV
- New FV
- Description
- 11-Mar-25
- 10
- 2
- Stock split from Rs. 10/- to Rs. 2/-.
